213 related articles for article (PubMed ID: 6249192)
1. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
Retsema JA; English AR; Girard AE
Antimicrob Agents Chemother; 1980 Apr; 17(4):615-22. PubMed ID: 6249192
[TBL] [Abstract][Full Text] [Related]
2. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
Moore BA; Brammer KW
Antimicrob Agents Chemother; 1981 Sep; 20(3):327-31. PubMed ID: 6272628
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of ampicillin and nafcillin against ampicillin-resistant Haemophilus influenzae.
Yogev R; Burkholder E; Davis AT
Antimicrob Agents Chemother; 1980 Mar; 17(3):461-3. PubMed ID: 6968540
[TBL] [Abstract][Full Text] [Related]
4. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
Yu PK; Washington JA
Antimicrob Agents Chemother; 1981 Jul; 20(1):63-5. PubMed ID: 6269484
[TBL] [Abstract][Full Text] [Related]
6. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
Wise R; Andrews JM; Bedford KA
J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
[No Abstract] [Full Text] [Related]
7. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
Dabernat H; Delmas C; Lareng MB
Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.
Thornsberry C; Baker CN; Kirven LA; Swenson JM
Antimicrob Agents Chemother; 1976 Jan; 9(1):70-3. PubMed ID: 1083202
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
Wexler HM; Harris B; Carter WT; Finegold SM
Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
[TBL] [Abstract][Full Text] [Related]
10. Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species.
Trestman I; Kaye D; Levison ME
Antimicrob Agents Chemother; 1979 Sep; 16(3):283-6. PubMed ID: 228593
[TBL] [Abstract][Full Text] [Related]
11. Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.
Fass RJ
Antimicrob Agents Chemother; 1981 Feb; 19(2):361-3. PubMed ID: 6289732
[TBL] [Abstract][Full Text] [Related]
12. Cyclacillin: in vitro activity against aerobic and anaerobic bacteria.
Thadepalli H; Roy I; Bach V
Chemotherapy; 1979; 25(5):303-7. PubMed ID: 383419
[TBL] [Abstract][Full Text] [Related]
13. Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.
Marks MI; Weinmaster G
Antimicrob Agents Chemother; 1975 Dec; 8(6):657-63. PubMed ID: 1082293
[TBL] [Abstract][Full Text] [Related]
14. Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 May; 45(5):1585-8. PubMed ID: 11302835
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of YTR 830.
Jacobs MR; Aronoff SC; Appelbaum PC; Yamabe S
J Chemother; 1989 Jun; 1(3):151-4. PubMed ID: 2552029
[TBL] [Abstract][Full Text] [Related]
16. Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):939-42. PubMed ID: 3032552
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.
Jones BM; Hafiz S; Duerden BI
Antimicrob Agents Chemother; 1986 Jun; 29(6):1110-2. PubMed ID: 3015016
[TBL] [Abstract][Full Text] [Related]
18. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
19. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.
Yogev R; Melick C; Kabat WJ
Antimicrob Agents Chemother; 1981 Jun; 19(6):993-6. PubMed ID: 6973952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
